UnitedHealth Group (UNH) Wins Fresh Confidence On Q1 Earnings, Is It Still 16% Undervalued?

Q1 Earnings Spark Fresh Attention On UnitedHealth Group

UnitedHealth Group (UNH) moved back into focus after robust Q1 earnings and growing recognition that its reported US$3b artificial intelligence spend is starting to deliver results for the business.

Despite the strong Q1 update, UnitedHealth Group’s share price has been choppy in the short term, with the stock down 2.4% over the past month and 2.5% over 90 days. However, the year-to-date share price return of 18.1% and 1-year total shareholder return of 17.2% point to momentum that has improved more over recent months than over the longer 3- and 5-year total return record.

Compare how UnitedHealth Group stacks up against other health care stocks utilizing AI by reviewing our curated list of 37 healthcare AI stocks.

UnitedHealth Group’s sharp year to date climb sits awkwardly next to its softer 3 year track record and recent pullback. Is this move mainly business fundamentals finally catching up, or sentiment swinging too far ahead of them?

Most Popular Narrative: 16.4% Undervalued

UnitedHealth Group's most followed valuation storyline pegs fair value at $475.23 per share, above the last close of $397.14. This puts a spotlight on what is driving that gap.

The analysts have a consensus price target of $475.23 for UnitedHealth Group based on their expectations of its future earnings growth, profit margins and other risk factors.

However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $529.0, and the most bearish reporting a price target of just $313.0.

Read the complete narrative.

Want to see what is behind that spread between bullish and bearish views? The narrative leans heavily on steadier revenue expansion, rising margins and a richer earnings base. The crucial piece is how those moving parts compound together over the next few years.

Result: Fair Value of $475.23 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

Still, Medicare rule changes and any stumble in executing the new CMS risk model could pressure UnitedHealth Group’s margins and challenge this undervaluation story.

Find out about the key risks to this UnitedHealth Group narrative.

Next Steps

Mixed messages around UnitedHealth Group can be confusing. Consider reviewing the full picture yourself, acting promptly, and weighing the 3 key rewards and 1 important warning sign.

Looking For More Investment Ideas Beyond UnitedHealth Group?

Do not stop with UnitedHealth Group. Fresh opportunities keep surfacing, and the right watchlist today can shape how your portfolio looks a few years from now.

• Target resilient balance sheets and cleaner fundamentals by checking the list of solid balance sheet and fundamentals (24 results).
• Hunt for quality at a discount by scanning the 49 high quality undervalued stocks.
• Stack your income stream by reviewing the 6 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com